Wegovy Flxt 1mg

Wegovy 1mg FlexTouch: A Detailed Product Description

Wegovy 1mg FlexTouch is a prescription medication designed for chronic weight management and to reduce the risk of major cardiovascular events in certain adult populations.

Name

• Brand Name: Wegovy 1mg FlexTouch
• Common Name: Semaglutide

Composition

• Active Ingredient: Semaglutide (1 mg per dose). Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking a natural hormone that regulates appetite and food intake.
• Inactive Ingredients: Disodium phosphate dihydrate, sodium chloride, water for injection, and hydrochloric acid or sodium hydroxide (to adjust pH).

Uses Wegovy is prescribed alongside a reduced-calorie diet and increased physical activity for:

• Weight Management: Adults and adolescents aged 12 years and older with obesity (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) with at least one weight-related comorbidity (e.g., type 2 diabetes, high blood pressure, or high cholesterol).
• Cardiovascular Risk Reduction: Adults with known cardiovascular disease who are overweight or obese, to lower the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death.

Dosage and Administration Wegovy is administered as a once-weekly subcutaneous injection. The starting dose is typically 0.25 mg once weekly, gradually increasing every 4 weeks under medical supervision. The typical dosing schedule involves:

• Weeks 1-4: 0.25 mg once weekly.
• Weeks 5-8: 0.5 mg once weekly.
• Weeks 9-12: 1 mg once weekly.
• Weeks 13-16: 1.7 mg once weekly.
• Week 17 onwards: 2.4 mg once weekly (maintenance dose). The injection can be given in the abdomen, thigh, or upper arm, rotating injection sites each week. It can be taken with or without food.

Side Effects

• Common Side Effects (may affect more than 1 in 10 people): Nausea, vomiting, diarrhea, constipation, headache, stomach pain, fatigue. These often subside as the body adjusts to the medication.
• Other Common Side Effects: Dizziness, indigestion, burping, gas, bloating, heartburn, hair loss, injection site reactions, gallstones, inflamed stomach.
• Serious Side Effects (uncommon to rare): Acute pancreatitis, severe allergic reactions (anaphylaxis), gallbladder problems (cholelithiasis, cholecystitis), kidney problems, and potential worsening of diabetic eye disease. Patients should seek immediate medical attention if symptoms of pancreatitis (severe, persistent abdominal pain) or a severe allergic reaction occur.

Precautions

• Thyroid C-Cell Tumors: Semaglutide has caused thyroid C-cell tumors in rodents; it is unknown if this risk applies to humans. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Pregnancy and Breastfeeding: Should not be used during pregnancy or while breastfeeding. Contraception is recommended for women of childbearing potential.
• Drug Interactions: Inform your doctor about all medications, especially other diabetes medications (like sulfonylureas or insulin) as Wegovy can increase the risk of low blood sugar. It can also affect the absorption of other oral medications due to slowed stomach emptying.
• Mental Health: Patients should be monitored for changes in mood, behavior, thoughts, or feelings, including suicidal thoughts.

Storage

• Before First Use: Store in a refrigerator between 2°C to 8°C (36°F to 46°F) in its original carton to protect from light.
• After First Use: The pen can be stored at room temperature (below 30°C or 86°F) or in the refrigerator (2°C to 8°C) for up to 6 weeks.
• Do Not Freeze: Do not use if it has been frozen.
• Keep out of reach of children.

Here are frequently asked questions about Wegovy (semaglutide) injection:

What is Wegovy used for?

Wegovy (semaglutide) is an injectable medicine primarily used for chronic weight management in adults and children aged 12 years and older who are considered obese, or adults who are overweight with at least one weight-related health condition (such as high blood pressure, type 2 diabetes, or high cholesterol). It is used alongside a reduced-calorie diet and increased physical activity. Additionally, Wegovy is approved to reduce the risk of major cardiovascular events like heart attack or stroke in adults with established cardiovascular disease who are obese or overweight, and to treat metabolic dysfunction-associated steatohepatitis (MASH) in some adults.

How does Wegovy work?

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the natural GLP-1 hormone in the body, which helps regulate appetite. By activating GLP-1 receptors in the brain, Wegovy helps reduce appetite and food intake, making you feel less hungry and more satisfied with smaller amounts of food. It also slows down the movement of food from your stomach to your intestines, contributing to a feeling of fullness for longer periods.

What is the usual dosage for Wegovy?

The starting dose for Wegovy is typically 0.25 mg injected once weekly. The dose is gradually increased every four weeks until a maintenance dose is reached, which is usually 1.7 mg or 2.4 mg once weekly. This gradual escalation helps your body adjust to the medication and minimizes side effects.

What are the common side effects of Wegovy?

Many people experience mild side effects, especially when starting the medication or increasing the dose. Common side effects include nausea, vomiting, diarrhea, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, and heartburn.

What are the serious side effects of Wegovy?

While less common, Wegovy can cause serious side effects such as pancreatitis (inflammation of the pancreas), gallbladder problems (including gallstones), kidney problems, increased heart rate, low blood sugar (especially in people with type 2 diabetes also taking insulin or sulfonylureas), and severe allergic reactions. There is also a boxed warning about the potential risk of thyroid C-cell tumors, including thyroid cancer. You should report any neck lumps, persistent hoarseness, difficulty swallowing or breathing to your doctor immediately.

Is Wegovy safe during pregnancy or breastfeeding?

Wegovy is generally not recommended during pregnancy. Animal studies have shown potential harm to the fetus, and the manufacturer advises stopping Wegovy at least two months before planning to become pregnant. It is not known if Wegovy passes into human breast milk or its effects on a breastfed child. Therefore, it is advised to discuss the risks and benefits with your doctor if you are breastfeeding or plan to breastfeed.

Can Wegovy be taken with other medications?

Wegovy can interact with other medications. It can increase the risk of low blood sugar when taken with insulin or sulfonylureas (other diabetes medications), and dose adjustments of these medications may be necessary. Wegovy also slows gastric emptying, which can affect the absorption of other oral medications. It should not be used with other semaglutide products or other GLP-1 receptor agonists. Always inform your healthcare provider about all prescription, over-the-counter medications, vitamins, and herbal supplements you are taking.

What should I do if I miss a dose of Wegovy?

If you miss a dose of Wegovy and your next scheduled dose is more than two days (48 hours) away, you should take the missed dose as soon as you remember. If your next dose is less than two days away, skip the missed dose and take your next dose on your regularly scheduled day. Do not take two doses within 48 hours. If you miss doses for two or more consecutive weeks, contact your healthcare provider for guidance, as you may need to restart at a lower dose.

How should Wegovy be stored?

Unused Wegovy pens should generally be stored in the refrigerator between 36°F and 46°F (2°C and 8°C). Keep them in their original carton to protect them from light. Once a pen is in use, or if refrigeration is not possible, it can be kept at room temperature (between 46°F and 86°F or 8°C and 30°C) for up to 28 days. Wegovy should never be frozen, and any pen that has been frozen must be discarded.